AP
QGEN icon

Antipodes Partners’s Qiagen QGEN Stock Holding History

Antipodes Partners’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Sell
940
-1,049
-53% -$39K ﹤0.01% 120
2026
Q1 		$79.6K Buy
1,989
+352
+22% +$16.7K ﹤0.01% 96
2025
Q4 		$77.5K Buy
1,637
+111
+7% +$5.13K ﹤0.01% 93
2025
Q3 		$68.2K Sell
1,526
-1,040
-41% -$49.8K ﹤0.01% 91
2025
Q2 		$123K Buy
2,566
+221
+9% +$9.61K ﹤0.01% 70
2025
Q1 		$94.2K Buy
+2,345
New +$98.6K ﹤0.01% 74
2020
Q2 		– Sell
-80,127
Closed -$3.11M – 37
2020
Q1 		$3.11M Buy
+80,127
New +$3.13M 0.16% 32

Other funds holding QGEN

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Antipodes Partners's QGEN Position: Q2 2026 in Review

Antipodes Partners reduced its Qiagen (QGEN) stake by 53% in Q2 2026, selling an estimated $39K and leaving 940 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #120.

Antipodes Partners first reported a position in QGEN in Q1 2020 and has held it in 7 quarters since. The position peaked at $3.11M in Q1 2020. 155 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Antipodes Partners held 940 shares of Qiagen worth $36.8K as of Q2 2026.
  • Antipodes Partners sold 1,049 Qiagen shares in Q2 2026, an estimated $39K.
  • Qiagen made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #120 holding.
  • Antipodes Partners first reported a position in Qiagen in Q1 2020 and has held it in 7 quarters since.
  • Antipodes Partners's Qiagen position peaked at $3.11M in Q1 2020.
  • 155 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.